Orca Bio website screenshot

Orca Bio

Orca Bio is a late-stage biotechnology company, headquartered in Menlo Park, California with a cGMP manufacturing facility in Sacramento, developing high-precision allogeneic cell therapies for cancer and autoimmune diseases. Its single-cell sorting platform separates donor blood with high purity and speed to build proprietary, precisely-defined mixtures of immune and stem cells. Orca Bio's lead program TREGZI is a precision-engineered allogeneic T-cell immunotherapy for hematological malignancies, alongside investigational programs Orca-T and Orca-Q. As a clinical/therapeutics company it does not publish a public developer or API surface; this profile was surfaced as a portfolio company of Felicis and enriched with verified company identity and domain-security signals.

Orca Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cell Therapy, Immunotherapy, and Healthcare.

Orca Bio’s developer surface includes engineering blog, support, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
4.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyCell TherapyImmunotherapyHealthcareLife SciencesOncology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 4.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 1.2 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/orcabio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Orcabio Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 About
About

Source (apis.yml)

apis.yml Raw ↑ 
aid: orcabio
name: Orca Bio
description: Orca Bio is a late-stage biotechnology company, headquartered in Menlo Park, California with a cGMP manufacturing
  facility in Sacramento, developing high-precision allogeneic cell therapies for cancer and autoimmune diseases. Its single-cell
  sorting platform separates donor blood with high purity and speed to build proprietary, precisely-defined mixtures of immune
  and stem cells. Orca Bio's lead program TREGZI is a precision-engineered allogeneic T-cell immunotherapy for hematological
  malignancies, alongside investigational programs Orca-T and Orca-Q. As a clinical/therapeutics company it does not publish
  a public developer or API surface; this profile was surfaced as a portfolio company of Felicis and enriched with verified
  company identity and domain-security signals.
url: https://raw.githubusercontent.com/api-evangelist/orcabio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- felicis
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-08-08'
image: https://orcabio.com/wp-content/themes/orca-corporate-theme/assets/img/favicon/favicon-196x196.png
tags:
- Company
- Biotechnology
- Cell Therapy
- Immunotherapy
- Healthcare
- Life Sciences
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/orcabio-domain-security.yml
- type: Website
  url: https://orcabio.com
- type: Blog
  url: https://orcabio.com/newsroom/
- type: About
  url: https://orcabio.com/our-company/
- type: Support
  url: https://orcabio.com/contact-us/
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-merged-from:
- orca-bio